Cellect Biotechnology Ltd.
Cellect Biotechnology Ltd. APOP Peers
See (APOP) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| APOP | $13.17 | +0.38% | 129.02M | -15.42 | -$0.85 | N/A |
| VRTX | $421.16 | -2.51% | 108.15B | -110.25 | -$3.82 | N/A |
| REGN | $571.36 | -0.49% | 60.65B | 14.53 | $39.32 | +0.15% |
| SGEN | $228.74 | -0.07% | 43.15B | -57.19 | -$4.00 | N/A |
| ALNY | $267.55 | +0.26% | 34.89B | -126.80 | -$2.11 | N/A |
| ARGX | $532.27 | -1.88% | 32.50B | 32.50 | $16.38 | N/A |
| BNTX | $92.09 | -2.56% | 22.14B | -25.65 | -$3.59 | N/A |
| BGNE | $184.71 | +0.49% | 20.21B | -22.55 | -$8.19 | N/A |
| DNA-WT | $0.27 | -2.76% | 18.73B | N/A | N/A | N/A |
| RPRX | $32.29 | -1.61% | 18.16B | 13.18 | $2.45 | +2.63% |
Stock Comparison
APOP vs VRTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, VRTX has a market cap of 108.15B. Regarding current trading prices, APOP is priced at $13.17, while VRTX trades at $421.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas VRTX's P/E ratio is -110.25. In terms of profitability, APOP's ROE is +2.27%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, APOP is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs REGN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, REGN has a market cap of 60.65B. Regarding current trading prices, APOP is priced at $13.17, while REGN trades at $571.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas REGN's P/E ratio is 14.53. In terms of profitability, APOP's ROE is +2.27%, compared to REGN's ROE of +0.15%. Regarding short-term risk, APOP is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs SGEN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, SGEN has a market cap of 43.15B. Regarding current trading prices, APOP is priced at $13.17, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas SGEN's P/E ratio is -57.19. In terms of profitability, APOP's ROE is +2.27%, compared to SGEN's ROE of -0.17%. Regarding short-term risk, APOP is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs ALNY Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ALNY has a market cap of 34.89B. Regarding current trading prices, APOP is priced at $13.17, while ALNY trades at $267.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ALNY's P/E ratio is -126.80. In terms of profitability, APOP's ROE is +2.27%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, APOP is less volatile compared to ALNY. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ARGX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ARGX has a market cap of 32.50B. Regarding current trading prices, APOP is priced at $13.17, while ARGX trades at $532.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ARGX's P/E ratio is 32.50. In terms of profitability, APOP's ROE is +2.27%, compared to ARGX's ROE of +0.16%. Regarding short-term risk, APOP is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BNTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BNTX has a market cap of 22.14B. Regarding current trading prices, APOP is priced at $13.17, while BNTX trades at $92.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BNTX's P/E ratio is -25.65. In terms of profitability, APOP's ROE is +2.27%, compared to BNTX's ROE of -0.03%. Regarding short-term risk, APOP is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BGNE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BGNE has a market cap of 20.21B. Regarding current trading prices, APOP is priced at $13.17, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BGNE's P/E ratio is -22.55. In terms of profitability, APOP's ROE is +2.27%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, APOP is less volatile compared to BGNE. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs DNA-WT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, DNA-WT has a market cap of 18.73B. Regarding current trading prices, APOP is priced at $13.17, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, APOP's ROE is +2.27%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, APOP is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RPRX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RPRX has a market cap of 18.16B. Regarding current trading prices, APOP is priced at $13.17, while RPRX trades at $32.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RPRX's P/E ratio is 13.18. In terms of profitability, APOP's ROE is +2.27%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, APOP is less volatile compared to RPRX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs SMMT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, SMMT has a market cap of 16.78B. Regarding current trading prices, APOP is priced at $13.17, while SMMT trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas SMMT's P/E ratio is -66.91. In terms of profitability, APOP's ROE is +2.27%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, APOP is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs UTHR Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, UTHR has a market cap of 13.52B. Regarding current trading prices, APOP is priced at $13.17, while UTHR trades at $299.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas UTHR's P/E ratio is 11.93. In terms of profitability, APOP's ROE is +2.27%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, APOP is less volatile compared to UTHR. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs KRTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, KRTX has a market cap of 12.60B. Regarding current trading prices, APOP is priced at $13.17, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas KRTX's P/E ratio is -28.09. In terms of profitability, APOP's ROE is +2.27%, compared to KRTX's ROE of -0.25%. Regarding short-term risk, APOP is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs EXEL Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, EXEL has a market cap of 12.30B. Regarding current trading prices, APOP is priced at $13.17, while EXEL trades at $44.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas EXEL's P/E ratio is 25.37. In terms of profitability, APOP's ROE is +2.27%, compared to EXEL's ROE of +0.24%. Regarding short-term risk, APOP is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs GMAB Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, GMAB has a market cap of 11.86B. Regarding current trading prices, APOP is priced at $13.17, while GMAB trades at $19.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas GMAB's P/E ratio is 11.16. In terms of profitability, APOP's ROE is +2.27%, compared to GMAB's ROE of +0.24%. Regarding short-term risk, APOP is less volatile compared to GMAB. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs INCY Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, INCY has a market cap of 11.84B. Regarding current trading prices, APOP is priced at $13.17, while INCY trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas INCY's P/E ratio is 305.80. In terms of profitability, APOP's ROE is +2.27%, compared to INCY's ROE of +0.01%. Regarding short-term risk, APOP is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BMRN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BMRN has a market cap of 11.26B. Regarding current trading prices, APOP is priced at $13.17, while BMRN trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BMRN's P/E ratio is 21.74. In terms of profitability, APOP's ROE is +2.27%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, APOP is less volatile compared to BMRN. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RXDX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RXDX has a market cap of 9.56B. Regarding current trading prices, APOP is priced at $13.17, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RXDX's P/E ratio is -56.47. In terms of profitability, APOP's ROE is +2.27%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, APOP is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs ASND Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ASND has a market cap of 9.49B. Regarding current trading prices, APOP is priced at $13.17, while ASND trades at $157.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ASND's P/E ratio is -24.07. In terms of profitability, APOP's ROE is +2.27%, compared to ASND's ROE of +1.91%. Regarding short-term risk, APOP is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs MRNA Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MRNA has a market cap of 9.29B. Regarding current trading prices, APOP is priced at $13.17, while MRNA trades at $24.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MRNA's P/E ratio is -2.75. In terms of profitability, APOP's ROE is +2.27%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, APOP is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs IMGN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, IMGN has a market cap of 8.73B. Regarding current trading prices, APOP is priced at $13.17, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas IMGN's P/E ratio is -111.55. In terms of profitability, APOP's ROE is +2.27%, compared to IMGN's ROE of +0.05%. Regarding short-term risk, APOP is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs CERE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CERE has a market cap of 8.19B. Regarding current trading prices, APOP is priced at $13.17, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CERE's P/E ratio is -16.47. In terms of profitability, APOP's ROE is +2.27%, compared to CERE's ROE of -0.99%. Regarding short-term risk, APOP is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs ROIVW Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ROIVW has a market cap of 7.83B. Regarding current trading prices, APOP is priced at $13.17, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, APOP's ROE is +2.27%, compared to ROIVW's ROE of -0.02%. Regarding short-term risk, APOP is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ROIV Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ROIV has a market cap of 7.61B. Regarding current trading prices, APOP is priced at $13.17, while ROIV trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ROIV's P/E ratio is -10.67. In terms of profitability, APOP's ROE is +2.27%, compared to ROIV's ROE of -0.02%. Regarding short-term risk, APOP is less volatile compared to ROIV. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs CORT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CORT has a market cap of 7.51B. Regarding current trading prices, APOP is priced at $13.17, while CORT trades at $70.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CORT's P/E ratio is 61.58. In terms of profitability, APOP's ROE is +2.27%, compared to CORT's ROE of +0.20%. Regarding short-term risk, APOP is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs TECH Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, TECH has a market cap of 7.50B. Regarding current trading prices, APOP is priced at $13.17, while TECH trades at $47.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas TECH's P/E ratio is 57.66. In terms of profitability, APOP's ROE is +2.27%, compared to TECH's ROE of +0.06%. Regarding short-term risk, APOP is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RVMD Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RVMD has a market cap of 7.35B. Regarding current trading prices, APOP is priced at $13.17, while RVMD trades at $39.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RVMD's P/E ratio is -9.85. In terms of profitability, APOP's ROE is +2.27%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, APOP is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs JAZZ Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, JAZZ has a market cap of 6.57B. Regarding current trading prices, APOP is priced at $13.17, while JAZZ trades at $106.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas JAZZ's P/E ratio is 14.48. In terms of profitability, APOP's ROE is +2.27%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, APOP is less volatile compared to JAZZ. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RETA Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RETA has a market cap of 6.57B. Regarding current trading prices, APOP is priced at $13.17, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RETA's P/E ratio is -66.29. In terms of profitability, APOP's ROE is +2.27%, compared to RETA's ROE of +0.47%. Regarding short-term risk, APOP is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs BBIO Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BBIO has a market cap of 6.39B. Regarding current trading prices, APOP is priced at $13.17, while BBIO trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BBIO's P/E ratio is -9.46. In terms of profitability, APOP's ROE is +2.27%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, APOP is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BPMC Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BPMC has a market cap of 6.30B. Regarding current trading prices, APOP is priced at $13.17, while BPMC trades at $97.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BPMC's P/E ratio is -38.85. In terms of profitability, APOP's ROE is +2.27%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, APOP is less volatile compared to BPMC. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs MDGL Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MDGL has a market cap of 6.28B. Regarding current trading prices, APOP is priced at $13.17, while MDGL trades at $282.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MDGL's P/E ratio is -15.86. In terms of profitability, APOP's ROE is +2.27%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, APOP is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs HALO Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, HALO has a market cap of 5.90B. Regarding current trading prices, APOP is priced at $13.17, while HALO trades at $47.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas HALO's P/E ratio is 12.74. In terms of profitability, APOP's ROE is +2.27%, compared to HALO's ROE of +1.22%. Regarding short-term risk, APOP is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs VRNA Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, VRNA has a market cap of 5.71B. Regarding current trading prices, APOP is priced at $13.17, while VRNA trades at $67.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas VRNA's P/E ratio is -33.62. In terms of profitability, APOP's ROE is +2.27%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, APOP is less volatile compared to VRNA. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ABCM Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ABCM has a market cap of 5.52B. Regarding current trading prices, APOP is priced at $13.17, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, APOP's ROE is +2.27%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, APOP is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs ISEE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ISEE has a market cap of 5.51B. Regarding current trading prices, APOP is priced at $13.17, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ISEE's P/E ratio is -22.44. In terms of profitability, APOP's ROE is +2.27%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, APOP is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs TLX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, TLX has a market cap of 5.49B. Regarding current trading prices, APOP is priced at $13.17, while TLX trades at $16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas TLX's P/E ratio is 182.22. In terms of profitability, APOP's ROE is +2.27%, compared to TLX's ROE of +0.14%. Regarding short-term risk, APOP is less volatile compared to TLX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs TGTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, TGTX has a market cap of 5.30B. Regarding current trading prices, APOP is priced at $13.17, while TGTX trades at $33.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas TGTX's P/E ratio is 133.60. In terms of profitability, APOP's ROE is +2.27%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, APOP is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs IONS Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, IONS has a market cap of 5.19B. Regarding current trading prices, APOP is priced at $13.17, while IONS trades at $32.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas IONS's P/E ratio is -10.90. In terms of profitability, APOP's ROE is +2.27%, compared to IONS's ROE of -0.00%. Regarding short-term risk, APOP is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs AXSM Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, AXSM has a market cap of 5.10B. Regarding current trading prices, APOP is priced at $13.17, while AXSM trades at $103.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas AXSM's P/E ratio is -17.97. In terms of profitability, APOP's ROE is +2.27%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, APOP is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs NUVL Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, NUVL has a market cap of 5.10B. Regarding current trading prices, APOP is priced at $13.17, while NUVL trades at $71.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas NUVL's P/E ratio is -16.07. In terms of profitability, APOP's ROE is +2.27%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, APOP is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ALKS Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ALKS has a market cap of 5.05B. Regarding current trading prices, APOP is priced at $13.17, while ALKS trades at $30.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ALKS's P/E ratio is 14.58. In terms of profitability, APOP's ROE is +2.27%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, APOP is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs ADMA Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ADMA has a market cap of 4.65B. Regarding current trading prices, APOP is priced at $13.17, while ADMA trades at $19.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ADMA's P/E ratio is 23.18. In terms of profitability, APOP's ROE is +2.27%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, APOP is less volatile compared to ADMA. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ALPN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ALPN has a market cap of 4.46B. Regarding current trading prices, APOP is priced at $13.17, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ALPN's P/E ratio is -101.52. In terms of profitability, APOP's ROE is +2.27%, compared to ALPN's ROE of -0.15%. Regarding short-term risk, APOP is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs OPT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, OPT has a market cap of 4.20B. Regarding current trading prices, APOP is priced at $13.17, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas OPT's P/E ratio is -1.52. In terms of profitability, APOP's ROE is +2.27%, compared to OPT's ROE of +2.60%. Regarding short-term risk, APOP is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs MRTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MRTX has a market cap of 4.12B. Regarding current trading prices, APOP is priced at $13.17, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MRTX's P/E ratio is -4.82. In terms of profitability, APOP's ROE is +2.27%, compared to MRTX's ROE of -0.40%. Regarding short-term risk, APOP is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs KRYS Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, KRYS has a market cap of 3.80B. Regarding current trading prices, APOP is priced at $13.17, while KRYS trades at $131.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas KRYS's P/E ratio is 31.51. In terms of profitability, APOP's ROE is +2.27%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, APOP is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs PCVX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, PCVX has a market cap of 3.80B. Regarding current trading prices, APOP is priced at $13.17, while PCVX trades at $29.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas PCVX's P/E ratio is -7.37. In terms of profitability, APOP's ROE is +2.27%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, APOP is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RYZB Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RYZB has a market cap of 3.75B. Regarding current trading prices, APOP is priced at $13.17, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RYZB's P/E ratio is -57.86. In terms of profitability, APOP's ROE is +2.27%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, APOP is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs CBAY Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CBAY has a market cap of 3.73B. Regarding current trading prices, APOP is priced at $13.17, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CBAY's P/E ratio is -32.81. In terms of profitability, APOP's ROE is +2.27%, compared to CBAY's ROE of -0.32%. Regarding short-term risk, APOP is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs PTCT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, PTCT has a market cap of 3.71B. Regarding current trading prices, APOP is priced at $13.17, while PTCT trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas PTCT's P/E ratio is 7.18. In terms of profitability, APOP's ROE is +2.27%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, APOP is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RYTM Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RYTM has a market cap of 3.64B. Regarding current trading prices, APOP is priced at $13.17, while RYTM trades at $57.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RYTM's P/E ratio is -20.46. In terms of profitability, APOP's ROE is +2.27%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, APOP is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs CYTK Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CYTK has a market cap of 3.58B. Regarding current trading prices, APOP is priced at $13.17, while CYTK trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CYTK's P/E ratio is -5.67. In terms of profitability, APOP's ROE is +2.27%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, APOP is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs SRPT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, SRPT has a market cap of 3.51B. Regarding current trading prices, APOP is priced at $13.17, while SRPT trades at $35.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas SRPT's P/E ratio is -13.54. In terms of profitability, APOP's ROE is +2.27%, compared to SRPT's ROE of -0.20%. Regarding short-term risk, APOP is less volatile compared to SRPT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs SWTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, SWTX has a market cap of 3.48B. Regarding current trading prices, APOP is priced at $13.17, while SWTX trades at $46.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas SWTX's P/E ratio is -13.55. In terms of profitability, APOP's ROE is +2.27%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, APOP is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs RNA Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RNA has a market cap of 3.42B. Regarding current trading prices, APOP is priced at $13.17, while RNA trades at $28.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RNA's P/E ratio is -9.47. In terms of profitability, APOP's ROE is +2.27%, compared to RNA's ROE of -0.27%. Regarding short-term risk, APOP is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs RARE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, RARE has a market cap of 3.28B. Regarding current trading prices, APOP is priced at $13.17, while RARE trades at $34.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas RARE's P/E ratio is -5.96. In terms of profitability, APOP's ROE is +2.27%, compared to RARE's ROE of -1.86%. Regarding short-term risk, APOP is less volatile compared to RARE. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ACLX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ACLX has a market cap of 3.25B. Regarding current trading prices, APOP is priced at $13.17, while ACLX trades at $59.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ACLX's P/E ratio is -19.74. In terms of profitability, APOP's ROE is +2.27%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, APOP is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs SLNO Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, SLNO has a market cap of 3.21B. Regarding current trading prices, APOP is priced at $13.17, while SLNO trades at $69.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas SLNO's P/E ratio is -15.97. In terms of profitability, APOP's ROE is +2.27%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, APOP is less volatile compared to SLNO. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs CRSP Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CRSP has a market cap of 3.07B. Regarding current trading prices, APOP is priced at $13.17, while CRSP trades at $35.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CRSP's P/E ratio is -7.93. In terms of profitability, APOP's ROE is +2.27%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, APOP is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs AKRO Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, AKRO has a market cap of 3.02B. Regarding current trading prices, APOP is priced at $13.17, while AKRO trades at $37.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas AKRO's P/E ratio is -10.10. In terms of profitability, APOP's ROE is +2.27%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, APOP is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs VKTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, VKTX has a market cap of 2.98B. Regarding current trading prices, APOP is priced at $13.17, while VKTX trades at $26.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas VKTX's P/E ratio is -22.91. In terms of profitability, APOP's ROE is +2.27%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, APOP is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs CRNX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CRNX has a market cap of 2.93B. Regarding current trading prices, APOP is priced at $13.17, while CRNX trades at $31.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CRNX's P/E ratio is -8.23. In terms of profitability, APOP's ROE is +2.27%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, APOP is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs SRRK Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, SRRK has a market cap of 2.90B. Regarding current trading prices, APOP is priced at $13.17, while SRRK trades at $30.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas SRRK's P/E ratio is -12.36. In terms of profitability, APOP's ROE is +2.27%, compared to SRRK's ROE of -1.29%. Regarding short-term risk, APOP is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ACAD Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ACAD has a market cap of 2.87B. Regarding current trading prices, APOP is priced at $13.17, while ACAD trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ACAD's P/E ratio is 12.53. In terms of profitability, APOP's ROE is +2.27%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, APOP is less volatile compared to ACAD. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs MORF Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MORF has a market cap of 2.86B. Regarding current trading prices, APOP is priced at $13.17, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MORF's P/E ratio is -14.88. In terms of profitability, APOP's ROE is +2.27%, compared to MORF's ROE of -0.27%. Regarding short-term risk, APOP is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs MOR Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MOR has a market cap of 2.86B. Regarding current trading prices, APOP is priced at $13.17, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MOR's P/E ratio is -12.64. In terms of profitability, APOP's ROE is +2.27%, compared to MOR's ROE of +7.43%. Regarding short-term risk, APOP is less volatile compared to MOR. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs CPRX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CPRX has a market cap of 2.85B. Regarding current trading prices, APOP is priced at $13.17, while CPRX trades at $23.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CPRX's P/E ratio is 14.90. In terms of profitability, APOP's ROE is +2.27%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, APOP is less volatile compared to CPRX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs MRUS Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MRUS has a market cap of 2.80B. Regarding current trading prices, APOP is priced at $13.17, while MRUS trades at $40.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MRUS's P/E ratio is -9.71. In terms of profitability, APOP's ROE is +2.27%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, APOP is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs PTGX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, PTGX has a market cap of 2.71B. Regarding current trading prices, APOP is priced at $13.17, while PTGX trades at $43.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas PTGX's P/E ratio is 56.12. In terms of profitability, APOP's ROE is +2.27%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, APOP is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs KDNY Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, KDNY has a market cap of 2.71B. Regarding current trading prices, APOP is priced at $13.17, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas KDNY's P/E ratio is -12.47. In terms of profitability, APOP's ROE is +2.27%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, APOP is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs MYOV Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MYOV has a market cap of 2.62B. Regarding current trading prices, APOP is priced at $13.17, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MYOV's P/E ratio is -14.05. In terms of profitability, APOP's ROE is +2.27%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, APOP is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs MTSR Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MTSR has a market cap of 2.57B. Regarding current trading prices, APOP is priced at $13.17, while MTSR trades at $24.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MTSR's P/E ratio is -12.06. In terms of profitability, APOP's ROE is +2.27%, compared to MTSR's ROE of -0.55%. Regarding short-term risk, APOP is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs LEGN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, LEGN has a market cap of 2.55B. Regarding current trading prices, APOP is priced at $13.17, while LEGN trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas LEGN's P/E ratio is -28.96. In terms of profitability, APOP's ROE is +2.27%, compared to LEGN's ROE of -0.16%. Regarding short-term risk, APOP is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs PRVB Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, PRVB has a market cap of 2.38B. Regarding current trading prices, APOP is priced at $13.17, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas PRVB's P/E ratio is -16.43. In terms of profitability, APOP's ROE is +2.27%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, APOP is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs APGE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, APGE has a market cap of 2.37B. Regarding current trading prices, APOP is priced at $13.17, while APGE trades at $39.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas APGE's P/E ratio is -11.04. In terms of profitability, APOP's ROE is +2.27%, compared to APGE's ROE of -0.19%. Regarding short-term risk, APOP is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs MLTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MLTX has a market cap of 2.35B. Regarding current trading prices, APOP is priced at $13.17, while MLTX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MLTX's P/E ratio is -19.57. In terms of profitability, APOP's ROE is +2.27%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, APOP is less volatile compared to MLTX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs LBPH Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, LBPH has a market cap of 2.34B. Regarding current trading prices, APOP is priced at $13.17, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas LBPH's P/E ratio is -26.66. In terms of profitability, APOP's ROE is +2.27%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, APOP is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs IMVT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, IMVT has a market cap of 2.34B. Regarding current trading prices, APOP is priced at $13.17, while IMVT trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas IMVT's P/E ratio is -5.26. In terms of profitability, APOP's ROE is +2.27%, compared to IMVT's ROE of -0.78%. Regarding short-term risk, APOP is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs XENE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, XENE has a market cap of 2.28B. Regarding current trading prices, APOP is priced at $13.17, while XENE trades at $29.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas XENE's P/E ratio is -9.88. In terms of profitability, APOP's ROE is +2.27%, compared to XENE's ROE of -0.32%. Regarding short-term risk, APOP is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs DICE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, DICE has a market cap of 2.27B. Regarding current trading prices, APOP is priced at $13.17, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas DICE's P/E ratio is -21.91. In terms of profitability, APOP's ROE is +2.27%, compared to DICE's ROE of +0.56%. Regarding short-term risk, APOP is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.
APOP vs VCYT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, VCYT has a market cap of 2.23B. Regarding current trading prices, APOP is priced at $13.17, while VCYT trades at $28.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas VCYT's P/E ratio is 67.83. In terms of profitability, APOP's ROE is +2.27%, compared to VCYT's ROE of +0.02%. Regarding short-term risk, APOP is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs MIRM Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, MIRM has a market cap of 2.20B. Regarding current trading prices, APOP is priced at $13.17, while MIRM trades at $44.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas MIRM's P/E ratio is -27.57. In terms of profitability, APOP's ROE is +2.27%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, APOP is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs IBRX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, IBRX has a market cap of 2.20B. Regarding current trading prices, APOP is priced at $13.17, while IBRX trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas IBRX's P/E ratio is -4.37. In terms of profitability, APOP's ROE is +2.27%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, APOP is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs CALT Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, CALT has a market cap of 2.15B. Regarding current trading prices, APOP is priced at $13.17, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas CALT's P/E ratio is -22.73. In terms of profitability, APOP's ROE is +2.27%, compared to CALT's ROE of -2.10%. Regarding short-term risk, APOP is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs VCEL Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, VCEL has a market cap of 2.13B. Regarding current trading prices, APOP is priced at $13.17, while VCEL trades at $42.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas VCEL's P/E ratio is 846.00. In terms of profitability, APOP's ROE is +2.27%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, APOP is less volatile compared to VCEL. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs NAMS Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, NAMS has a market cap of 2.11B. Regarding current trading prices, APOP is priced at $13.17, while NAMS trades at $18.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas NAMS's P/E ratio is -10.19. In terms of profitability, APOP's ROE is +2.27%, compared to NAMS's ROE of -0.26%. Regarding short-term risk, APOP is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs APLS Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, APLS has a market cap of 2.10B. Regarding current trading prices, APOP is priced at $13.17, while APLS trades at $16.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas APLS's P/E ratio is -9.28. In terms of profitability, APOP's ROE is +2.27%, compared to APLS's ROE of -1.00%. Regarding short-term risk, APOP is less volatile compared to APLS. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs ARWR Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, ARWR has a market cap of 2.06B. Regarding current trading prices, APOP is priced at $13.17, while ARWR trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas ARWR's P/E ratio is -2.90. In terms of profitability, APOP's ROE is +2.27%, compared to ARWR's ROE of -0.46%. Regarding short-term risk, APOP is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BCRX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BCRX has a market cap of 2.05B. Regarding current trading prices, APOP is priced at $13.17, while BCRX trades at $9.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BCRX's P/E ratio is -37.75. In terms of profitability, APOP's ROE is +2.27%, compared to BCRX's ROE of +0.15%. Regarding short-term risk, APOP is less volatile compared to BCRX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs AAPG Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, AAPG has a market cap of 2.03B. Regarding current trading prices, APOP is priced at $13.17, while AAPG trades at $23.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas AAPG's P/E ratio is -31.69. In terms of profitability, APOP's ROE is +2.27%, compared to AAPG's ROE of N/A. Regarding short-term risk, APOP is less volatile compared to AAPG. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs DNLI Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, DNLI has a market cap of 2.03B. Regarding current trading prices, APOP is priced at $13.17, while DNLI trades at $13.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas DNLI's P/E ratio is -5.23. In terms of profitability, APOP's ROE is +2.27%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, APOP is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs LGND Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, LGND has a market cap of 2.03B. Regarding current trading prices, APOP is priced at $13.17, while LGND trades at $105.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas LGND's P/E ratio is -14.42. In terms of profitability, APOP's ROE is +2.27%, compared to LGND's ROE of -0.16%. Regarding short-term risk, APOP is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BHVN Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BHVN has a market cap of 2.01B. Regarding current trading prices, APOP is priced at $13.17, while BHVN trades at $19.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BHVN's P/E ratio is -2.13. In terms of profitability, APOP's ROE is +2.27%, compared to BHVN's ROE of -2.57%. Regarding short-term risk, APOP is less volatile compared to BHVN. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BLTE Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BLTE has a market cap of 1.96B. Regarding current trading prices, APOP is priced at $13.17, while BLTE trades at $61.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BLTE's P/E ratio is -52.20. In terms of profitability, APOP's ROE is +2.27%, compared to BLTE's ROE of -0.31%. Regarding short-term risk, APOP is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs KYMR Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, KYMR has a market cap of 1.94B. Regarding current trading prices, APOP is priced at $13.17, while KYMR trades at $29.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas KYMR's P/E ratio is -9.57. In terms of profitability, APOP's ROE is +2.27%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, APOP is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs HRMY Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, HRMY has a market cap of 1.92B. Regarding current trading prices, APOP is priced at $13.17, while HRMY trades at $33.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas HRMY's P/E ratio is 12.74. In terms of profitability, APOP's ROE is +2.27%, compared to HRMY's ROE of +0.24%. Regarding short-term risk, APOP is less volatile compared to HRMY. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs NAMSW Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, NAMSW has a market cap of 1.90B. Regarding current trading prices, APOP is priced at $13.17, while NAMSW trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas NAMSW's P/E ratio is N/A. In terms of profitability, APOP's ROE is +2.27%, compared to NAMSW's ROE of -0.26%. Regarding short-term risk, APOP is less volatile compared to NAMSW. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs TVTX Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, TVTX has a market cap of 1.87B. Regarding current trading prices, APOP is priced at $13.17, while TVTX trades at $21.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas TVTX's P/E ratio is -7.59. In terms of profitability, APOP's ROE is +2.27%, compared to TVTX's ROE of -11.84%. Regarding short-term risk, APOP is less volatile compared to TVTX. This indicates potentially lower risk in terms of short-term price fluctuations for APOP.
APOP vs BLU Comparison
APOP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APOP stands at 129.02M. In comparison, BLU has a market cap of 1.87B. Regarding current trading prices, APOP is priced at $13.17, while BLU trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APOP currently has a P/E ratio of -15.42, whereas BLU's P/E ratio is -20.20. In terms of profitability, APOP's ROE is +2.27%, compared to BLU's ROE of -0.06%. Regarding short-term risk, APOP is more volatile compared to BLU. This indicates potentially higher risk in terms of short-term price fluctuations for APOP.